Jerry Kanellos
Chief Scientific OfficerDr. Jerry Kanellos, Ph.D was Chief Scientific Officer at Immuron Limited since November 1, 2023 and served as its Chief Operating Officer until August 2026 and serves as its Chief Scientific Officer since August 2026. Dr. Kanellos served as its Chief Operating Officer at Immuron Limited since July 28, 2015 and had been its Interim Chief Executive Officer since March 25, 2020 until June 27, 2022. Dr. Kanellos served as Interim Chief Executive Officer of Immuron Limited since August 1, 2017 until November 16, 2018 and served as its Scientific Officer. From 2008 to 2012, Dr. Kanellos was the Chief Operating Officer of TransBio Limited. Dr. Kanellos has experience in the pharmaceutical and biotechnology industry and held leadership roles in business development, project management, intellectual property portfolio management, research and development and senior management. Dr. Kanellos worked as a consultant to the biotech industry and provided development and commercialisation strategies for various bodies including academic institutes, private and publicly listed companies and government departments. He was involved in the establishment and management of several startup biotechnology companies. He served in research and development at CSL Limited, Dr. Kanellos has considerable experience in the drug development process, formulation development through to pharmaceutical scale-up and cGMP manufacture successfully leading the Chemistry, Manufacturing and Controls (CMC) programs for the approval, manufacture and launch of several products. Dr. Kanellos has experience in vaccine development, clinical trial management and regulatory affairs. He holds a PhD in Medicine from the University of Melbourne.
公司职务
- 公司名称Immuron Limited股票代码IMRN职务Chief Scientific Officer共事同僚
- SGSteven George LydeamoreChief Executive Officer
- PBPaul BrennanIndependent Non-Executive Chairman
- FPFlavio PalumboChief Commercial Officer
- ALAaron LauritaChief Financial Officer
- DLDavid LyonHead of Marketing
- DPDaniel PollockIndependent Non-Executive Director
- DLDena LyrasMember of Advisory Board
- RSRavi SavarirayanIndependent Non-Executive Director
- GSGlenn S. TillotsonMember of Advisory Board
